Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lyra Therapeutics (LYRA) Tax Rate (2023 - 2025)

Quarterly Tax Rate rose 3.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.04% for FY2025, 0.0% changed from the prior year.

Lyra Therapeutics' Tax Rate history spans 3 years, with the latest figure at 0.03% for Q4 2025.

  • Tax Rate came in at 0.03% for Q4 2025, up from 0.05% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.02% in Q2 2024 to a low of 0.11% in Q4 2023.
  • The 3-year median for Tax Rate is 0.06% (2024), against an average of 0.06%.
  • Year-over-year, Tax Rate increased 6bps in 2024 and then changed 0bps in 2025.
  • Lyra Therapeutics' Tax Rate stood at 0.11% in 2023, then soared by 51bps to 0.05% in 2024, then surged by 47bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Tax Rate are 0.03% (Q4 2025), 0.05% (Q3 2025), and 0.03% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 56.85
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 5.61
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 17.68
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 12.51
8 Evaxion A 65.12 Bn 65.10 Bn - -6.79
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 7.07
10 Lyra Therapeutics - - - -0.03

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.03
Dec 31, 2025 -0.03
Sep 30, 2025 -0.05
Sep 30, 2025 -0.05
Jun 30, 2025 -0.03
Jun 30, 2025 -0.03
Mar 31, 2025 -0.05
Mar 31, 2025 -0.05
Dec 31, 2024 -0.05
Dec 31, 2024 -0.05
Sep 30, 2024 -0.06
Sep 30, 2024 -0.06
Jun 30, 2024 -0.02
Jun 30, 2024 -0.02
Mar 31, 2024 -0.06
Mar 31, 2024 -0.06
Dec 31, 2023 -0.11
Dec 31, 2023 -0.11
Sep 30, 2023 -0.10
Sep 30, 2023 -0.10
Jun 30, 2023 -0.08
Jun 30, 2023 -0.08
Mar 31, 2023 -0.09
Mar 31, 2023 -0.09